Biotechnology firm jobs boost for Waterford

A MAJOR Waterford employer, which has begun construction of a new €61 million manufacturing facility in the city, has received a boost that could translate into more jobs.

The Genzyme Corporation, which already employs 300 in Waterford, has received the green light to market a revolutionary muscle drug in the European Union, which could mean more jobs down the line at it’s new Waterford plant.

The drug, Myozyme, has just been approved by the EU for long-term enzyme replacement therapy in patients with Pompe disease, a debilitating, progressive and often fatal disorder affecting fewer than 10,000 people worldwide.